Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...
European safety regulators have launched an investigation into the safety of a batch of the Oxford University/AstraZeneca COVID-19 vaccine, as countries including Denmark suspended its use as a ...
The National Institutes of Health, which falls under the jurisdiction of HHS, has terminated grants for research into vaccine ...
New inhaled COVID-19 vaccine by McMaster enters phase-2 trials in Canada. The vaccine aims to provide stronger, needle-free ...
AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational ...
The boss of drugmaker AstraZeneca has said he was “very disappointed” with the firm’s move to scrap plans for a £450 million vaccine plant in Liverpool, but insisted the business case did ...
In June 2007, AstraZeneca completed the acquisition of vaccine maker MedImmune ... right patient, right safety and right commercial. ‘Right patient’, for example, is about finding the patient ...
AstraZeneca boosts cancer therapies push with ... February 20, 2025 US vaccine advisory meeting postponed after Kennedy takes top health job A meeting of U.S. vaccine advisers set for late ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback